Antibody Testing Market Is Expected To Progress At A CAGR of 7.5% To Reach US$ 18.89 Billion by 2034: Fact.MR Report

Antibody Testing Market Is Expected To Progress At A CAGR of 7.5% To Reach US$ 18.89 Billion by 2034: Fact.MR Report

GlobeNewswire

Published

Rising Cases of Infectious Diseases Propelling Demand for Antibody Testing for Accurate and Reliable Diagnosis

Rockville, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Sales of antibody testing products are pegged at US$ 9.17 billion in 2024, according to a new study published by Fact.MR, a market research and competitive intelligence provider. The global antibody testing market is forecasted to expand at a 7.5% CAGR from 2024 to 2034.In recent years, several indications, including oncology, cardiovascular, diabetes, pregnancy, and others need antibody testing solutions. Easy availability of these diagnostic kits is predicted to contribute to their increased popularity across regions. Adoption of antibody testing enables healthcare professionals to provide tailored treatment to patients based on their immune response to specific pathogens.

*Get Free Sample Copy of This Report:*
*https://www.factmr.com/connectus/sample?flag=S&rep_id=9194*

Growth of the market is also attributed to the advancements in disease biomarkers. Technological advancements in genomics, metabolomics, and proteomics assist researchers in providing effective healthcare solutions. Development of certain condition-specific biomarkers with affordability, applicability, accuracy, and overall health outcomes are predicted to attract trends in the market. Rising awareness about the benefits of health insurance programs is also forecasted to contribute to the increased demand for antibody testing kits, thus generating opportunities for market players.

*Report Attribute* *Details*
Value Projection (2034) US$ 18.89 Billion
Growth Rate (2024-2034) 7.5% CAGR
No. of pages 170 Pages
No. of Tables 84 Tables
No. of Figures 112 Figures

*Key Takeaway from Market Study *

· The global antibody testing market is estimated at US$ 9.17 billion in 2024.
· Worldwide sales of antibody testing kits are projected to reach US$ 18.89 billion by the end of 2034.
· The global market is forecasted to expand at 7.5% CAGR from 2024 to 2034.
· Sales of antibody testing products in the United States are projected to rose at 8.4% CAGR and reach US$ 6.36 billion by the end of 2034.
· North America is estimated to hold 37.1% share of the global market by the end of 2034.*“Rising cases of chronic diseases, including infectious diseases, autoimmune diseases, and cancer, is predicted to stimulate demand for immunoassays, including antibody tests, for their diagnosis and monitoring,” *says a Fact.MR analyst.

*Key Market Players *

· Thermos Fisher Scientific,
· Abbott Laboratories,
· Bio-Rad Laboratories, Inc.,
· F. Hoffmann La Roche,
· Beckton,
· Agilent Technologies,
· Dickinson and Company,
· DiaSorin,
· Trinity Biotech,
· Abcam,
· Zeus Scientific are leading antibody testing solution providers.*Rising Investments by Market Players in R&D Activities for Product Development in the United States*

The market in the United States is projected to hold a 90.8% share of North American market revenue by 2034. Players from the United States are spending a significant amount on R&D activities for technological advancements in antibody test products. In addition, the dominance of the United States is attributed to the increasing adoption of antibody testing in several indications, including infectious diseases, oncology, pregnancy, cardiovascular diseases, endocrine diseases, and others.

*Get Customization on this Report for Specific Research Solutions:*
*https://www.factmr.com/connectus/sample?flag=RC&rep_id=9194*

*More Valuable Insights* *on Offer *

Fact.MR, in its new offering, presents an unbiased analysis of the antibody testing market, presenting historical demand data for 2018 to 2023 and forecast statistics for 2024 to 2034.

The study divulges essential insights into the market based on product (serological test kits [serological assay test kits, and serological rapid assay kits], immunoglobulin kits [immunoglobulin assay test kits, immunoglobulin rapid assay kits], lateral flow assay kits [lateral flow assay test kits, lateral flow rapid assay kits], chemicals & reagents, consumables), indication (pregnancy, cardiovascular diseases, autoimmune diseases, infectious diseases, oncology, endocrine diseases, diabetes), and end user (hospitals, academic & research institutes, diagnostic laboratories, biopharmaceutical companies, homecare settings), across six major regions of the world (North America, Europe, East Asia, Latin America, South Asia & Oceania, and MEA).

*Explore More Related Studies Published by Fact.MR Research: *

*Antibiotic Residue Test Kits Market:* The global antibiotic residue test kits market size is currently being valued at US$ 184.5 million in 2023, and is projected to reach US$ 333.4 million by 2033-end

*Preimplantation Genetic Testing Market:* The preimplantation genetic testing market is projected to grow at nearly 9% CAGR and is likely to register an impressive valuation through 2032.

*Nipah Virus Testing Market:* The Nipah Virus Testing market is anticipated to grow with a CAGR of 5.5% in the forecast period. The market is further expected to surpass a valuation of USD 3374.95 Million by end of 2032.

*About Fact.MR**:*

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.

*Contact: *
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
*Sales Team: *sales@factmr.com
*Follow Us: *LinkedIn | Twitter | Blog

Full Article